Annual EBITDA
-$70.45 M
-$78.86 M-938.54%
December 31, 2023
Summary
- As of February 8, 2025, TOI annual EBITDA is -$70.45 million, with the most recent change of -$78.86 million (-938.54%) on December 31, 2023.
- During the last 3 years, TOI annual EBITDA has fallen by -$59.16 million (-524.04%).
- TOI annual EBITDA is now -938.54% below its all-time high of $8.40 million, reached on December 31, 2022.
Performance
TOI EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$12.31 M
-$472.00 K-3.99%
September 30, 2024
Summary
- As of February 8, 2025, TOI quarterly EBITDA is -$12.31 million, with the most recent change of -$472.00 thousand (-3.99%) on September 30, 2024.
- Over the past year, TOI quarterly EBITDA has increased by +$4.10 million (+24.98%).
- TOI quarterly EBITDA is now -159.99% below its all-time high of $20.53 million, reached on March 31, 2022.
Performance
TOI Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$56.12 M
+$1.52 M+2.63%
September 30, 2024
Summary
- As of February 8, 2025, TOI TTM EBITDA is -$56.12 million, with the most recent change of +$1.52 million (+2.63%) on September 30, 2024.
- Over the past year, TOI TTM EBITDA has increased by +$3.50 million (+5.88%).
- TOI TTM EBITDA is now -549.34% below its all-time high of $12.49 million, reached on March 31, 2022.
Performance
TOI TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TOI EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -938.5% | +25.0% | +5.9% |
| 3 y3 years | -524.0% | -184.7% | -1798.6% |
| 5 y5 years | -10000.0% | -184.7% | -1798.6% |
TOI EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -938.5% | at low | -160.0% | +54.8% | -549.3% | +20.3% |
| 5 y | 5-year | -938.5% | at low | -160.0% | +54.8% | -549.3% | +20.3% |
| alltime | all time | -938.5% | at low | -160.0% | +54.8% | -549.3% | +20.3% |
Oncology Institute EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$12.31 M(+4.0%) | -$56.12 M(-2.6%) |
| Jun 2024 | - | -$11.84 M(-27.9%) | -$57.64 M(-3.3%) |
| Mar 2024 | - | -$16.41 M(+5.6%) | -$59.63 M(-15.4%) |
| Dec 2023 | -$70.45 M(-938.5%) | -$15.55 M(+12.4%) | -$70.45 M(+12.5%) |
| Sep 2023 | - | -$13.83 M(0.0%) | -$62.64 M(+28.2%) |
| Jun 2023 | - | -$13.83 M(-49.2%) | -$48.87 M(+24.1%) |
| Mar 2023 | - | -$27.24 M(+252.3%) | -$39.37 M(-568.5%) |
| Dec 2022 | $8.40 M | -$7.73 M(>+9900.0%) | $8.40 M(+87.1%) |
| Sep 2022 | - | -$67.00 K(-98.5%) | $4.49 M(+35.9%) |
| Jun 2022 | - | -$4.33 M(-121.1%) | $3.30 M(-73.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $20.53 M(-276.3%) | $12.49 M(-257.4%) |
| Dec 2021 | -$7.94 M(-29.7%) | -$11.64 M(+829.3%) | -$7.94 M(-22.8%) |
| Sep 2021 | - | -$1.25 M(-125.8%) | -$10.28 M(+11.4%) |
| Jun 2021 | - | $4.86 M(+4760.0%) | -$9.23 M(-23.9%) |
| Mar 2021 | - | $100.00 K(-100.7%) | -$12.13 M(-0.8%) |
| Dec 2020 | -$11.29 M(-3776.3%) | -$13.99 M(+6946.4%) | -$12.23 M(-794.4%) |
| Sep 2020 | - | -$198.50 K(-110.1%) | $1.76 M(-10.1%) |
| Jun 2020 | - | $1.96 M(-583.3%) | $1.96 M(-583.3%) |
| Dec 2019 | $307.10 K | - | - |
| Dec 2018 | - | -$405.40 K | -$405.40 K |
FAQ
- What is Oncology Institute annual EBITDA?
- What is the all time high annual EBITDA for Oncology Institute?
- What is Oncology Institute annual EBITDA year-on-year change?
- What is Oncology Institute quarterly EBITDA?
- What is the all time high quarterly EBITDA for Oncology Institute?
- What is Oncology Institute quarterly EBITDA year-on-year change?
- What is Oncology Institute TTM EBITDA?
- What is the all time high TTM EBITDA for Oncology Institute?
- What is Oncology Institute TTM EBITDA year-on-year change?
What is Oncology Institute annual EBITDA?
The current annual EBITDA of TOI is -$70.45 M
What is the all time high annual EBITDA for Oncology Institute?
Oncology Institute all-time high annual EBITDA is $8.40 M
What is Oncology Institute annual EBITDA year-on-year change?
Over the past year, TOI annual EBITDA has changed by -$78.86 M (-938.54%)
What is Oncology Institute quarterly EBITDA?
The current quarterly EBITDA of TOI is -$12.31 M
What is the all time high quarterly EBITDA for Oncology Institute?
Oncology Institute all-time high quarterly EBITDA is $20.53 M
What is Oncology Institute quarterly EBITDA year-on-year change?
Over the past year, TOI quarterly EBITDA has changed by +$4.10 M (+24.98%)
What is Oncology Institute TTM EBITDA?
The current TTM EBITDA of TOI is -$56.12 M
What is the all time high TTM EBITDA for Oncology Institute?
Oncology Institute all-time high TTM EBITDA is $12.49 M
What is Oncology Institute TTM EBITDA year-on-year change?
Over the past year, TOI TTM EBITDA has changed by +$3.50 M (+5.88%)